IRIS Accounts Production v25.1.4.42 11499548 Board of Directors 1.9.24 31.8.25 31.8.25 0 false true false false false 423 4310 3887 iso4217:GBP iso4217:USD iso4217:EUR xbrli:shares xbrli:pure utr:tonnes utr:kWh 11499548 2024-08-31 11499548 2025-08-31 11499548 2024-09-01 2025-08-31 11499548 2023-08-31 11499548 2023-09-01 2024-08-31 11499548 2024-08-31 11499548 ns15:EnglandWales 2024-09-01 2025-08-31 11499548 ns14:PoundSterling 2024-09-01 2025-08-31 11499548 ns10:Director1 2024-09-01 2025-08-31 11499548 ns10:PrivateLimitedCompanyLtd 2024-09-01 2025-08-31 11499548 ns10:Micro-entities 2024-09-01 2025-08-31 11499548 ns10:AuditExempt-NoAccountantsReport 2024-09-01 2025-08-31 11499548 ns10:FullAccounts 2024-09-01 2025-08-31 11499548 ns10:Director1 41 2024-09-01 2025-08-31 11499548 ns10:Director1 41 2025-08-31 11499548 ns5:CurrentFinancialInstruments 2025-08-31 11499548 ns5:CurrentFinancialInstruments 2024-08-31 11499548 ns5:Non-currentFinancialInstruments 2025-08-31 11499548 ns5:Non-currentFinancialInstruments 2024-08-31 11499548 ns10:Director2 2024-09-01 2025-08-31 11499548 ns10:Director2 2 2024-08-31 11499548 ns10:Director2 2 2023-08-31 11499548 ns10:Director2 2 2024-09-01 2025-08-31 11499548 ns10:Director2 2 2023-09-01 2024-08-31 11499548 ns10:Director2 2 2025-08-31 11499548 ns10:Director2 2 2024-08-31

REGISTERED NUMBER: 11499548 (England and Wales)

| Unaudited Financial Statements |

| for the Year Ended 31 August 2025 |

| for |

| TRENT MEDICAL CONSULTANCY LTD |

TRENT MEDICAL CONSULTANCY LTD (BY SHARES) (REGISTERED NUMBER: 11499548) |

Contents of the Financial Statements

for the Year Ended 31 August 2025

Page |

| Balance Sheet | 1 |

TRENT MEDICAL CONSULTANCY LTD (BY SHARES) (REGISTERED NUMBER: 11499548) |

Balance Sheet

31 August 2025

| 2025 | 2024 |

£ | £ | £ | £ |

FIXED ASSETS | 1,150 |  | 1,533 |  |

CURRENT ASSETS | 130,300 |  | 112,243 |  |

CREDITORS

Amounts falling due within one year | (17,442 | ) | (26,513 | ) |

NET CURRENT ASSETS | 112,858 |  | 85,730 |  |

TOTAL ASSETS LESS CURRENT LIABILITIES | 114,008 |  | 87,263 |  |

CREDITORS

Amounts falling due after more than one year | (86,231 | ) | (58,321 | ) |

NET ASSETS | 27,777 |  | 28,942 |  |

CAPITAL AND RESERVES | 27,777 |  | 28,942 |  |

NOTES TO THE FINANCIAL STATEMENTS

1. | AVERAGE NUMBER OF EMPLOYEES

| The average number of employees during the year was NIL (2024 - 3 ) .

2. | DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

| The following advances and credits to directors subsisted during the years ended 31 August 2025 and 31 August 2024:

2025 | 2024 |

£ | £ |

| Harriet Louise Singh and Sadmeet Singh

| Balance outstanding at start of year | - |  | - |  |

| Amounts advanced | 423 |  | - |  |

| Amounts repaid | (4,310 | ) | - |  |

| Amounts written off | - |  | - |  |

| Amounts waived | - |  | - |  |

| Balance outstanding at end of year | (3,887 | ) | - |  |

| Dividends during the period to the holding company = £40,000 (£40,000 in 2024)

TRENT MEDICAL CONSULTANCY LTD (BY SHARES) (REGISTERED NUMBER: 11499548) |

Balance Sheet - continued

31 August 2025

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 August 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 August 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a) | ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b) | preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the Board of Directors and authorised for issue on 6 January 2026 and were signed on its behalf by:

Sadmeet Singh - Director